| 1 |
Myxoinflammatory Fibroblastic Sarcoma |
|
| | Hao Wu, William B. Laskin | | | Surgical Pathology Clinics. 2023; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Recent updates in the diagnosis of soft tissue tumors: Newly described tumor entities, newer immunohistochemical and genetic markers, concepts, including “inter-tumor relationships” |
|
| | Bharat Rekhi | | | Indian Journal of Pathology and Microbiology. 2021; 64(3): 448 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Hemosiderotic Fibrolipomatous Tumor, Pleomorphic Hyalinizing Angiectatic Tumor, and Myxoinflammatory Fibroblastic Sarcoma |
|
| | Jennifer M. Boland,Andrew L. Folpe | | | Advances In Anatomic Pathology. 2017; 24(5): 268 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
TGFBR3 and MGEA5 rearrangements are much more common in “hybrid” hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study |
|
| | Riyam T. Zreik,Jodi M. Carter,William R. Sukov,William A. Ahrens,Karen J. Fritchie,Elizabeth A. Montgomery,Sharon W. Weiss,Andrew L. Folpe | | | Human Pathology. 2016; 53: 14 | | | [Pubmed] [Google Scholar] [DOI] | |
|
